Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Migraine Drugs Market?

The market size of migraine medications has seen significant expansion in the past few years. The market is projected to escalate from $5.38 billion in 2024 to $5.71 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. The historical growth can be credited to progress in drug formulations, enhanced recognition and diagnosis, stress and lifestyle aspects, proliferation of generic drugs, and the emergence of cgrp inhibitors.

The market size for migraine medications is predicted to experience significant expansion in the coming years, reaching a value of “$7.08 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the advent of personalized medicine techniques, the rise of telemedicine and remote medical consultations, alterations in healthcare policies and insurance coverage, and the mounting global migraine prevalence. Key trends anticipated for the forecast period encompass targeted treatments, telemedicine and remote consultations, patient-oriented strategies, digital therapeutic approaches, the use of biosimilars in treating migraines, and clinical research and trials.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp

What Core Drivers Are Expected To Influence The Migraine Drugs Market?

The rising numbers of the female demographic are anticipated to catalyze the expansion of the migraine drugs market. The term ‘female population’ refers to the cumulative count of women across all age brackets who reside in each country or region over a specific duration. Migraines are notably more prevalent in women as compared to men, this can be attributed to a blend of genetic, hormonal, and environmental influences. For example, the World Population Prospects 2022, published by the United Nations, a US-based intergovernmental organization, estimates that in 2022, the global female population stands at 4.00 billion. This accounts for 49.75% of the global population and it is predicted that by 2049, women will surpass men in population count. Hence, the increasing female population fuels the expansion of the migraine drugs market.

What Are The Key Segment Trends Observed In The Migraine Drugs Market?

The migraine drugs market covered in this report is segmented –

1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants

2) By Route of Administration: Oral, Injectable, Other Routes

3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users

Subsegments:

1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan

2) By Beta Blockers: Propranolol, Metoprolol, Timolol

3) By Angiotensin Blockers: Candesartan, Losartan

4) By Tricyclics: Amitriptyline, Nortriptyline

5) By Anticonvulsants: Topiramate, Valproate

Which Disruptive Trends Are Driving Change Across The Migraine Drugs Market?

Leading businesses in the migraine drugs market, such as Zavzpret, are concentrating on the creation of inventive medicinal products in order to cater to patients’ needs and establish a competitive advantage in their field. Zavzpret, a medication administered through a nasal spray, is specifically formulated to help adults suffering from migraines, whether with aura or without. In March 2023, Pfizer, a pharmaceutical firm based in the United States, garnered approval from the Food and Drug Administration, also headquartered in the U.S., to market Zavzpret. This approval marked the first of its kind for a zavegepant (CGRP receptor antagonist) nasal spray designed to treat migraines in their acute stage, and operates by targeting the calcitonin gene-related peptide (CGRP). Zavzpret’s approval represents a milestone in the offering of a novel remedy for people living with migraines, particularly beneficial to those experiencing accompanying nausea and vomiting during episodes, as well as those unable to take triptans due to associated cardiovascular risks.

Which Firms Are Driving Innovation Within The Migraine Drugs Market?

Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy’s Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report

What Regional Factors Are Accelerating Growth In The Migraine Drugs Market?

North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13484&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model